We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,109

Crying Over Spilt Eye Drops
  • Weil Gotshal & Manges LLP
  • USA
  • November 27 2017

Last month the Third Circuit reversed an order of dismissal issued by the District of New Jersey regarding a putative class action brought by


Inside the Courts - An Update From Skadden Securities Litigators
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • November 5 2017

Judge Patti B. Saris denied the Bank of New York Mellon’s (BNY Mellon) motion to strike putative class representative Ashby Henderson. BNY Mellon


Class Actions Involving “Natural” Labeling Remain on Hold in Anticipation of FDA Guidance
  • Morgan Lewis & Bockius LLP
  • USA
  • October 25 2017

The US Food and Drug Administration (FDA) opened a public comment period on November 12, 2015, seeking information and comments on use of the term


M.D. PA Declines to Dismiss MonitoringDeclaratory Judgment Action vs. Blood Temperature Regulation Device
  • Reed Smith LLP
  • USA
  • October 25 2017

We thought we were on a winning streak on medical monitoring. In August, we blogged about plaintiff lawyers stumbling in their efforts to walk the


Design Defect Claims Preempted In Eye Drop Litigation
  • Dechert LLP
  • USA
  • October 19 2017

Do as I say, not as I do. A crutch used by parents worldwide to justify their own bad habits while trying to ensure their children don't repeat them


Food & Beverage Litigation Update - Issue 649
  • Shook Hardy & Bacon LLP
  • USA
  • October 9 2017

A report from the Office of the Inspector General (OIG) of the U.S. Department of Health and Human Services has concluded that the Food and Drug


Ninth Circuit Analyzes Statements Concerning FDA Feedback, in In re Atossa Genetics, Inc. Securities Litigation (August 18, 2017)
  • Lane Powell PC
  • USA
  • October 4 2017

On August 18, 2017, a Ninth Circuit panel affirmed in part, reversed in part, and vacated in part the district court's dismissal of the amended


Food & Beverage Litigation Update - Issue 647
  • Shook Hardy & Bacon LLP
  • USA
  • September 11 2017

Implementing an Executive Order titled "Reducing Regulation and Controlling Regulatory Costs," the U.S. Food and Drug Administration (FDA) has opened


FDA Trip Leads to Securities Stumble: The Gravity of Regulatory Due Diligence
  • Arent Fox LLP
  • USA
  • September 7 2017

After three years of litigation, a medical device manufacturer has agreed to pay $7 million to settle a class action lawsuit that claimed the company


Yes, Your “Natural” Label is Still a Liability
  • Davis Wright Tremaine LLP
  • USA
  • August 31 2017

Mid-year reports have shown that there has been a resurgence in “all natural” litigation against food product companies in 2017 - an expected 30